Rozema v. United States Department of Health & Human Services
This text of 682 F. App'x 72 (Rozema v. United States Department of Health & Human Services) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
SUMMARY ORDER
Kyle Thomas Rozema, pro se, appeals from a judgment of the District Court (Suddaby, C.J.) granting summary judgment in favor of the United States Food and Drug Administration (“FDA”) and the United States Department of Health and Human Services with respect to Rozema’s Freedom of Information Act (“FOIA”) request. Rozema requested that the FDA [73]*73disclose data it had gathered detailing the quantity of menthol in cigarettes by brand. The District Court held that the information was properly withheld under FOIA’s exemption for trade secrets and confidential commercial information. We assume the parties’ familiarity with the facts and record of the prior proceedings, to which we refer only as necessary to explain our decision to affirm.
FOIA exempts from disclosure materials that contain “trade secrets and commercial or financial information obtained from a person and privileged or confidential.” 5 U.S.C. § 552(b)(4). Rozema acknowledges that the data he requested—the quantity of menthol in cigarettes by brand—contains trade secrets and confidential commercial information within the meaning of the FOIA exemption and is, therefore, exempt from disclosure. See Inner City Press/Cmty. on the Move v. Bd. of Governors of the Fed. Reserve Sys., 463 F.3d 239, 244 (2d Cir. 2006). Rozema has not identified any statutory provision that requires disclosure of the requested data. The FDA has not included menthol on its list of harmful and potentially harmful constituents, so the agency is not required to disclose menthol-related data under the Family Smoking Prevention and Tobacco Control Act. See 21 U.S.C. §§ 387d(d), (e). Nor has Congress obligated the FDA to add menthol to its harmful constituents list and disclose the data. See id. § 387g(e)(3). We therefore conclude that the FDA correctly applied the FOIA exemption to deny Rozema’s FOIA request. 5 U.S.C. § 552(b)(4).
We have considered Rozema’s remaining arguments and conclude that they are without merit. For the foregoing reasons, the judgment of the District Court is AFFIRMED.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
682 F. App'x 72, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rozema-v-united-states-department-of-health-human-services-ca2-2017.